Skip to main content
Journal cover image

NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS

Publication ,  Conference
Khasraw, M; McDonald, K; Yip, S; Verhaak, RG; Heimberger, AB; Hall, M; Barnes, E; Hovey, E; Ellingson, BM; Lwin, Z
Published in: NEURO-ONCOLOGY
September 1, 2018

Duke Scholars

Published In

NEURO-ONCOLOGY

EISSN

1523-5866

ISSN

1522-8517

Publication Date

September 1, 2018

Volume

20

Start / End Page

236 / 236

Location

Stockholm, SWEDEN

Publisher

OXFORD UNIV PRESS INC

Conference Name

13th Meeting of the European-Association-of-Neurooncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khasraw, M., McDonald, K., Yip, S., Verhaak, R. G., Heimberger, A. B., Hall, M., … Lwin, Z. (2018). NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS. In NEURO-ONCOLOGY (Vol. 20, pp. 236–236). Stockholm, SWEDEN: OXFORD UNIV PRESS INC.
Khasraw, M., K. McDonald, S. Yip, R. G. Verhaak, A. B. Heimberger, M. Hall, E. Barnes, E. Hovey, B. M. Ellingson, and Z. Lwin. “NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS.” In NEURO-ONCOLOGY, 20:236–236. OXFORD UNIV PRESS INC, 2018.
Khasraw M, McDonald K, Yip S, Verhaak RG, Heimberger AB, Hall M, et al. NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 236–236.
Khasraw, M., et al. “NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS.” NEURO-ONCOLOGY, vol. 20, OXFORD UNIV PRESS INC, 2018, pp. 236–236.
Khasraw M, McDonald K, Yip S, Verhaak RG, Heimberger AB, Hall M, Barnes E, Hovey E, Ellingson BM, Lwin Z. NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 236–236.
Journal cover image

Published In

NEURO-ONCOLOGY

EISSN

1523-5866

ISSN

1522-8517

Publication Date

September 1, 2018

Volume

20

Start / End Page

236 / 236

Location

Stockholm, SWEDEN

Publisher

OXFORD UNIV PRESS INC

Conference Name

13th Meeting of the European-Association-of-Neurooncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences